Home Page
About us
Overview
Organization
Technology
Abiprot
TM
-antibody platform
Abiprot Select
TM
Portfolio
Overview
OT-1096 in TNBC
aTRPV1 & aTRPA1 in pain
aKRAS in colorectal cancer
Collaborations in type 2 diabetes
Corporate Governance
Annual General Meeting
Previous Annual General Meetings
Board of Directors and Management
Articles of Association
Investors Relations
Financial Reports
Annual Reports for the years 2016-2019
News
Press Releases
Publications, conferences & press
Contact
Oblique Therapeutics
>
News
>
2020
>
November
Home Page
About us
Overview
Organization
Technology
Abiprot
TM
-antibody platform
Abiprot Select
TM
Portfolio
Overview
OT-1096 in TNBC
aTRPV1 & aTRPA1 in pain
aKRAS in colorectal cancer
Collaborations in type 2 diabetes
Corporate Governance
Annual General Meeting
Previous Annual General Meetings
Board of Directors and Management
Articles of Association
Investors Relations
Financial Reports
Annual Reports for the years 2016-2019
News
Press Releases
Publications, conferences & press
Contact
News
Archive
April 2021
March 2021
November 2020
October 2020
September 2020
June 2020
November 2019
October 2019
July 2019
March 2019
January 2019
November 2018
Categories
Company updates
News
18
Nov
2020
Oblique Therapeutics AB, raises 98 MSEK in a private placement investment round.
